Reps. Katko, Brindisi to FDA: Prevent Drug Shortages for CNY Lupus, Arthritis Patients
April 10, 2020
April 10, 2020
SYRACUSE, New York, April 10 -- Rep. John Katko, R-New York, issued the following news release:
U.S. Reps. John Katko (NY-24) and Anthony Brindisi (NY-22) requested that the U.S. Food and Drug Administration (FDA) issue prescribing guidelines for medications being used to treat COVID-19, such as Hydroxychloroquine and Chloroquine, to ensure the availability of these drugs for patients in Central and Upstate New York suffering from a variety of other conditions and illnesses, as thes . . .
U.S. Reps. John Katko (NY-24) and Anthony Brindisi (NY-22) requested that the U.S. Food and Drug Administration (FDA) issue prescribing guidelines for medications being used to treat COVID-19, such as Hydroxychloroquine and Chloroquine, to ensure the availability of these drugs for patients in Central and Upstate New York suffering from a variety of other conditions and illnesses, as thes . . .